These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 10837490)

  • 1. Novel gain-of-function mutations of platelet glycoprotein IBalpha by valine mutagenesis in the Cys209-Cys248 disulfide loop. Functional analysis under statis and dynamic conditions.
    Dong J; Schade AJ; Romo GM; Andrews RK; Gao S; McIntire LV; López JA
    J Biol Chem; 2000 Sep; 275(36):27663-70. PubMed ID: 10837490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics of GPIbalpha-vWF-A1 tether bond under flow: effect of GPIbalpha mutations on the association and dissociation rates.
    Kumar RA; Dong JF; Thaggard JA; Cruz MA; López JA; McIntire LV
    Biophys J; 2003 Dec; 85(6):4099-109. PubMed ID: 14645097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The mucin-like macroglycopeptide region of glycoprotein Ibalpha is required for cell adhesion to immobilized von Willebrand factor (VWF) under flow but not for static VWF binding.
    Li CQ; Dong JF; López JA
    Thromb Haemost; 2002 Oct; 88(4):673-7. PubMed ID: 12362242
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tyrosine sulfation of glycoprotein I(b)alpha. Role of electrostatic interactions in von Willebrand factor binding.
    Dong J; Ye P; Schade AJ; Gao S; Romo GM; Turner NT; McIntire LV; López JA
    J Biol Chem; 2001 May; 276(20):16690-4. PubMed ID: 11279169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The alpha1 helix-beta13 strand spanning Leu214 to Val229 of platelet glycoprotein Ibalpha facilitates the interaction with von Willebrand factor: evidence from characterization of the epitope of monoclonal antibody AP1.
    Peng Y; Berndt MC; Cruz MA; López JA
    Blood; 2004 Dec; 104(13):3971-8. PubMed ID: 15319289
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Requirement of leucine-rich repeats of glycoprotein (GP) Ibalpha for shear-dependent and static binding of von Willebrand factor to the platelet membrane GP Ib-IX-V complex.
    Shen Y; Romo GM; Dong JF; Schade A; McIntire LV; Kenny D; Whisstock JC; Berndt MC; López JA; Andrews RK
    Blood; 2000 Feb; 95(3):903-10. PubMed ID: 10648402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic force spectroscopy of glycoprotein Ib-IX and von Willebrand factor.
    Arya M; Kolomeisky AB; Romo GM; Cruz MA; López JA; Anvari B
    Biophys J; 2005 Jun; 88(6):4391-401. PubMed ID: 15764659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Type 2M von Willebrand disease: F606I and I662F mutations in the glycoprotein Ib binding domain selectively impair ristocetin- but not botrocetin-mediated binding of von Willebrand factor to platelets.
    Hillery CA; Mancuso DJ; Evan Sadler J; Ponder JW; Jozwiak MA; Christopherson PA; Cox Gill J; Paul Scott J; Montgomery RR
    Blood; 1998 Mar; 91(5):1572-81. PubMed ID: 9473222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Measurement of the binding forces between von Willebrand factor and variants of platelet glycoprotein Ibalpha using optical tweezers.
    Arya M; López JA; Romo GM; Dong JF; McIntire LV; Moake JL; Anvari B
    Lasers Surg Med; 2002; 30(4):306-12. PubMed ID: 11948601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gain of von Willebrand factor-binding function by mutagenesis of a species-conserved residue within the leucine-rich repeat region of platelet glycoprotein Ibalpha.
    Peng Y; Shrimpton CN; Dong JF; López JA
    Blood; 2005 Sep; 106(6):1982-7. PubMed ID: 15933060
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytoplasmic truncation of glycoprotein Ib alpha weakens its interaction with von Willebrand factor and impairs cell adhesion.
    Schade AJ; Arya M; Gao S; Diz-Küçükkaya R; Anvari B; McIntire LV; López JA; Dong JF
    Biochemistry; 2003 Feb; 42(7):2245-51. PubMed ID: 12590614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure and function of the von Willebrand factor A1 domain: analysis with monoclonal antibodies reveals distinct binding sites involved in recognition of the platelet membrane glycoprotein Ib-IX-V complex and ristocetin-dependent activation.
    De Luca M; Facey DA; Favaloro EJ; Hertzberg MS; Whisstock JC; McNally T; Andrews RK; Berndt MC
    Blood; 2000 Jan; 95(1):164-72. PubMed ID: 10607699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a novel 14-3-3zeta binding site within the cytoplasmic domain of platelet glycoprotein Ibalpha that plays a key role in regulating the von Willebrand factor binding function of glycoprotein Ib-IX.
    Yuan Y; Zhang W; Yan R; Liao Y; Zhao L; Ruan C; Du X; Dai K
    Circ Res; 2009 Dec; 105(12):1177-85. PubMed ID: 19875727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ristocetin-dependent, but not botrocetin-dependent, binding of von Willebrand factor to the platelet glycoprotein Ib-IX-V complex correlates with shear-dependent interactions.
    Dong JF; Berndt MC; Schade A; McIntire LV; Andrews RK; López JA
    Blood; 2001 Jan; 97(1):162-8. PubMed ID: 11133756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the phenotypic abnormality of platelet-type von Willebrand disease in a recombinant glycoprotein Ib alpha fragment.
    Murata M; Russell SR; Ruggeri ZM; Ware J
    J Clin Invest; 1993 May; 91(5):2133-7. PubMed ID: 8486780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mocarhagin, a novel cobra venom metalloproteinase, cleaves the platelet von Willebrand factor receptor glycoprotein Ibalpha. Identification of the sulfated tyrosine/anionic sequence Tyr-276-Glu-282 of glycoprotein Ibalpha as a binding site for von Willebrand factor and alpha-thrombin.
    Ward CM; Andrews RK; Smith AI; Berndt MC
    Biochemistry; 1996 Apr; 35(15):4929-38. PubMed ID: 8664285
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional analysis of the C-terminal flanking sequence of platelet glycoprotein Ib alpha using canine-human chimeras.
    Shen Y; Dong Jf JF; Romo GM; Arceneaux W; Aprico A; Gardiner EE; López JA; Berndt MC; Andrews RK
    Blood; 2002 Jan; 99(1):145-50. PubMed ID: 11756164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype changes resulting in high-affinity binding of von Willebrand factor to recombinant glycoprotein Ib-IX: analysis of the platelet-type von Willebrand disease mutations.
    Tait AS; Cranmer SL; Jackson SP; Dawes IW; Chong BH
    Blood; 2001 Sep; 98(6):1812-8. PubMed ID: 11535515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification of botrocetin from Bothrops jararaca venom. Analysis of the botrocetin-mediated interaction between von Willebrand factor and the human platelet membrane glycoprotein Ib-IX complex.
    Andrews RK; Booth WJ; Gorman JJ; Castaldi PA; Berndt MC
    Biochemistry; 1989 Oct; 28(21):8317-26. PubMed ID: 2557900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression and functional characterization of an abnormal platelet membrane glycoprotein Ib alpha (Met239 --> Val) reported in patients with platelet-type von Willebrand disease.
    Moriki T; Murata M; Kitaguchi T; Anbo H; Handa M; Watanabe K; Takahashi H; Ikeda Y
    Blood; 1997 Jul; 90(2):698-705. PubMed ID: 9226170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.